167 related articles for article (PubMed ID: 8515419)
1. 1,3,4-Oxadiazole, 1,3,4-thiadiazole, and 1,2,4-triazole analogs of the fenamates: in vitro inhibition of cyclooxygenase and 5-lipoxygenase activities.
Boschelli DH; Connor DT; Bornemeier DA; Dyer RD; Kennedy JA; Kuipers PJ; Okonkwo GC; Schrier DJ; Wright CD
J Med Chem; 1993 Jun; 36(13):1802-10. PubMed ID: 8515419
[TBL] [Abstract][Full Text] [Related]
2. Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally-active, nonulcerogenic antiinflammatory agents.
Mullican MD; Wilson MW; Connor DT; Kostlan CR; Schrier DJ; Dyer RD
J Med Chem; 1993 Apr; 36(8):1090-9. PubMed ID: 8478906
[TBL] [Abstract][Full Text] [Related]
3. Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitors.
Unangst PC; Shrum GP; Connor DT; Dyer RD; Schrier DJ
J Med Chem; 1992 Oct; 35(20):3691-8. PubMed ID: 1433181
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethylethyl)- 4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activity.
Unangst PC; Connor DT; Cetenko WA; Sorenson RJ; Kostlan CR; Sircar JC; Wright CD; Schrier DJ; Dyer RD
J Med Chem; 1994 Jan; 37(2):322-8. PubMed ID: 8295221
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
[TBL] [Abstract][Full Text] [Related]
6. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
7. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity.
Hamer RR; Tegeler JJ; Kurtz ES; Allen RC; Bailey SC; Elliott ME; Hellyer L; Helsley GC; Przekop P; Freed BS; White J; Martin LL
J Med Chem; 1996 Jan; 39(1):246-52. PubMed ID: 8568814
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal antiinflammatory agents, XVIII: C-5 functionalized 6,7-diphenyl-2,3-dihydro-1H-pyrrolizines as inhibitors of bovine cyclooxygenase and 5-lipoxygenase.
Dannhardt G; Kiefer W
Arch Pharm (Weinheim); 1994 Aug; 327(8):509-14. PubMed ID: 7944906
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors.
Kolasa T; Brooks CD; Rodriques KE; Summers JB; Dellaria JF; Hulkower KI; Bouska J; Bell RL; Carter GW
J Med Chem; 1997 Feb; 40(5):819-24. PubMed ID: 9057869
[TBL] [Abstract][Full Text] [Related]
11. Are tolfenamic acid and tenidap dual inhibitors of 5-lipoxygenase and cyclo-oxygenase?
Proudman KE; McMillan RM
Agents Actions; 1991 Sep; 34(1-2):121-4. PubMed ID: 1793015
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2008 Dec; 18(23):6138-41. PubMed ID: 18945614
[TBL] [Abstract][Full Text] [Related]
13. Conversion of a cyclooxygenase (CO) inhibitor into a 5-lipoxygenase (LO) inhibitor: a general route to novel orally active anti-inflammatory and anti-allergy drugs.
Kreft AF; Failli AA; Musser JH; Kubrak DM; Banker AL; Steffan R; Demerson CA; Nelson JA; Shah US; Gray W
Drugs Exp Clin Res; 1991; 17(8):381-7. PubMed ID: 1822830
[TBL] [Abstract][Full Text] [Related]
14. 1,2,4-Triazole-conjugated 1,3,4-thiadiazole hybrid scaffolds: A potent ameliorant of carrageenan-induced inflammation by lessening proinflammatory mediators.
Pathak P; Shukla PK; Naumovich V; Grishina M; Verma A; Potemkin V
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900233. PubMed ID: 31696959
[TBL] [Abstract][Full Text] [Related]
15. Role of corticosterone in modulation of eicosanoid biosynthesis and antiinflammatory activity by 5-lipoxygenase (5-LO) and cyclooxygenase (CO) inhibitors.
Tomchek LA; Hartman DA; Lewin AC; Calhoun W; Chau TT; Carlson RP
Agents Actions; 1991 Sep; 34(1-2):20-4. PubMed ID: 1665293
[TBL] [Abstract][Full Text] [Related]
16. Non-steroidal antiinflammatory agents. Synthesis and enzyme inhibition of 2-[4-(heteroarylmethyl)phenyl] propanoic acids and analogues.
Silvestri R; Pagnozzi E; Valoti M; Fusi F
Farmaco; 1994 Oct; 49(10):625-32. PubMed ID: 7826468
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
[TBL] [Abstract][Full Text] [Related]
18. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
19. Benzoselenazolinone derivatives designed to be glutathione peroxidase mimetics feature inhibition of cyclooxygenase/5-lipoxygenase pathways and anti-inflammatory activity.
Galet V; Bernier JL; Hénichart JP; Lesieur D; Abadie C; Rochette L; Lindenbaum A; Chalas J; Renaud de la Faverie JF; Pfeiffer B
J Med Chem; 1994 Sep; 37(18):2903-11. PubMed ID: 8071938
[TBL] [Abstract][Full Text] [Related]
20. The pharmacologic effects of 5-[3,5-bis(1,1-dimethylethyl)-4- hydroxyphenyl]-1,3,4-thiadiazole-2(3H)-thione, choline salt (CI-986), a novel inhibitor of arachidonic acid metabolism in models of inflammation, analgesia and gastric irritation.
Schrier DJ; Baragi VM; Connor DT; Dyer RD; Jordan JH; Imre KM; Lesch ME; Mullican MD; Okonkwo GC; Conroy MC
Prostaglandins; 1994 Jan; 47(1):17-30. PubMed ID: 8140259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
